98PRetrospective indirect comparison of alectinib phase II data vs ceritinib real-world data in ALK+ NSCLC after progression on crizotinibJ. Davies, M. Martinec,R. Martina,Paul Delmar, M. Coudert,Walter Bordogna,Sophie Golding, G. CraneAnnals of Oncology(2017)引用 1|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要